MARK LANKA, O.D.
Optometrist in BROKEN BOW, Oklahoma. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MARK LANKA, O.D. filed 358 Medicare Part D claims in 2023 as a Optometrist in BROKEN BOW, Oklahoma, prescribing 72% generic.
- 358
- Part D claims, 2023
- 72%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MARK LANKA, O.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
358 Top 43% higher than 57% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about MARK LANKA, O.D.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Oklahoma
How Optometrist compares to other specialties among Oklahoma providers
Optometrist share within Oklahoma
Optometrist is one of the more visible NUCC categories in Oklahoma
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Optometrist (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Optometrist ABMS/AOA estimate
Est. board-certified rate (Optometrist) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Optometrist US NPIs
Specialty board-certified rate — Optometrist estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MARK LANKA, O.D. appears in the CMS NPPES registry as a Optometrist provider holding O.D. credentials at 511 S PARK DR STE A, BROKEN BOW, OK, 74728, with a listed phone of (580) 584-3434. NPI 1679817506 was issued on 11/15/2012. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LANKA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 358 prescription claims written by this provider, covering 76 Medicare beneficiaries and totaling roughly $20K in drug spend, split 28% brand-name and 72% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1679817506 |
|---|---|
| Specialty | Optometrist |
| Credentials | O.D. |
| Gender | Male |
| NPI Issued | 11/15/2012 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MARK LANKA, O.D.'s current license status, disciplinary history, and board certifications with the Oklahoma State Board of Medical Licensure in Oklahoma before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where MARK LANKA, O.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Above average
28% brand-name claims vs 72% generic, on 358 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 436
- Total Day Supply
- 11,320
- Brand vs Generic
- 28% brand / 72% generic
- Brand Drug Cost
- $13K
- Generic Drug Cost
- $7K
Patient Demographics
- Average Patient Age
- 72.9 years
- Avg HCC Risk Score
- 1.06
- Gender Split
- 57% female / 43% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What MARK LANKA, O.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
171 claims
- Timolol Maleate 61
Timolol Maleate
61 claims
- Brimonidine Tartrate 19
Brimonidine Tartrate
19 claims
- Prednisolone Acetate 18
Prednisolone Acetate
18 claims
- Neomycin-Polymyxin… 16
Neomycin-Polymyxin-Dexameth
16 claims
- Valacyclovir 14
Valacyclovir
14 claims
| Drug | Claims |
|---|---|
| Latanoprost | 171 |
| Timolol Maleate | 61 |
| Brimonidine Tartrate | 19 |
| Prednisolone Acetate | 18 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 16 |
| Valacyclovir Valacyclovir Hcl | 14 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Optometrist Overview
How MARK LANKA, O.D. fits within the Optometrist landscape nationally.
MARK LANKA, O.D.'s 358 claims are above the specialty average of 257.
Nearby Optometrist Providers in Oklahoma
Other clinicians with the same primary specialty enrolled in Oklahoma, drawn from the same CMS NPPES roster as LANKA.
Compare Optometrist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Oklahoma
Frequently Asked Questions
What is MARK LANKA, O.D.'s specialty? ▼
How much does MARK LANKA, O.D. prescribe under Medicare Part D? ▼
Where is MARK LANKA, O.D. located? ▼
What is MARK LANKA, O.D.'s NPI number? ▼
Does MARK LANKA, O.D. prescribe more brand-name or generic drugs? ▼
How many Optometrist providers are there in the US? ▼
What drugs does MARK LANKA, O.D. prescribe most often? ▼
Does MARK LANKA, O.D. accept Medicare? ▼
How can I verify MARK LANKA, O.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology